Quarterly report pursuant to Section 13 or 15(d)

Common Stock Equivalents

v3.19.1
Common Stock Equivalents
9 Months Ended
Mar. 31, 2019
Equity [Abstract]  
Common Stock Equivalents

Note 5. Common Stock Equivalents

  

The Company had the following common stock equivalents at March 31, 2019 and 2018. These are excluded from the loss per share calculation as they are considered anti-dilutive.

  

    March 31,
2019
   

March 31,

 2018

 
Convertible Notes     4,960,800        
Options     2,177,314       1,263,859  
Warrants     708,651       754,809  
Total     7,846,765       2,018,668